Avanos Medical AVNS will release its quarterly earnings report on Wednesday, 2024-10-30. Here's a brief overview for investors ahead of the announcement.
Analysts anticipate Avanos Medical to report an earnings per share (EPS) of $0.35.
The market awaits Avanos Medical's announcement, with hopes high for news of surpassing estimates and providing upbeat guidance for the next quarter.
It's important for new investors to understand that guidance can be a significant driver of stock prices.
Historical Earnings Performance
In the previous earnings release, the company beat EPS by $0.05, leading to a 0.71% drop in the share price the following trading session.
Here's a look at Avanos Medical's past performance and the resulting price change:
| Quarter | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 |
|---|---|---|---|---|
| EPS Estimate | 0.29 | 0.21 | 0.37 | 0.28 |
| EPS Actual | 0.34 | 0.19 | 0.36 | 0.30 |
| Price Change % | -1.0% | -0.0% | 0.0% | 4.0% |
Market Performance of Avanos Medical's Stock
Shares of Avanos Medical were trading at $22.62 as of October 28. Over the last 52-week period, shares are up 8.99%. Given that these returns are generally positive, long-term shareholders are likely bullish going into this earnings release.
To track all earnings releases for Avanos Medical visit their earnings calendar on our site.
This article was generated by Benzinga's automated content engine and reviewed by an editor.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
